Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-10

Clinical Trial Update: Intravenous Atropine in Reducing Reperfusion Arrhythmias, Conduction Abnormalities and Hypotension in Inferior ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating intravenous atropine to reduce reperfusion arrhythmias, conduction abnormalities and hypotension in patients with inferior ST-elevati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Atropine sulfate (intravenous) (atropine sulfate)

Snippet

Sponsor: Ain Shams University | Conditions: Myocardial Infarction | Phase 4 | Status: COMPLETED